Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Calithera Biosciences To Present First Clinical Data From Development Program For Arginase Inhibitor CB-280 At NACFC 2021


Benzinga | Oct 21, 2021 12:11PM EDT

Calithera Biosciences To Present First Clinical Data From Development Program For Arginase Inhibitor CB-280 At NACFC 2021






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC